Overview

Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the safety, effectiveness and ease of use of subcutaneous (SC) rehydration using HYLENEX-augmented SC infusion of fluids and electrolytes for the rehydration of pediatric patients with mild to moderate dehydration.
Phase:
Phase 4
Details
Lead Sponsor:
Baxter Healthcare Corporation
Collaborators:
Halozyme Therapeutics
PPD